Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says

The insatiable demand for weight loss and diabetes drugs is still trouncing supply, even as Eli Lilly and Novo Nordisk work to increase production capacity.

Source: CNBC

Continue reading...